Contact
Contact us
EpiAxis is pioneering next-generation LSD1 inhibitors to unlock powerful, durable treatments for patients with aggressive solid tumours, transforming resistance into responsiveness, and science into hope.
Contact
EpiAxis is pioneering next-generation LSD1 inhibitors to unlock powerful, durable treatments for patients with aggressive solid tumours, transforming resistance into responsiveness, and science into hope.